Skip to main content

Table 1 Correlation between ERα/Src and ERα/PI3K interactions

From: Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant

Variable ERα/PI3K ≤9, no. (%) ERα/PI3K >9, no. (%) P
ERα/Src Low (≤ 10) 181 (69.6) 68 (44.2) <0.001
High (> 10) 79 (30.4) 86 (55.8)